Indeks
Some Canadian provinces have stopped using a batch of the A/H1-N1 flu vaccine. The decision was made after six people in the country experienced severe allergic reactions, including the death of an 80-year-old man from Quebec.
The Public Health Agency of Canada and the manufacturer of the vaccine have asked nearly half the country's 13 provinces and territories to stop using a batch of nearly 200,000 doses.
Although the vaccine did well in early testing, some Canadians wonder if it is perfectly safe. However, health officials have warned that it is too early to connect the country's one death case with the injection. They also stress the benefit of the vaccine far outweighs any risk associated with being immunized.
The Public Health Agency of Canada and the manufacturer of the vaccine have asked nearly half the country's 13 provinces and territories to stop using a batch of nearly 200,000 doses.
Although the vaccine did well in early testing, some Canadians wonder if it is perfectly safe. However, health officials have warned that it is too early to connect the country's one death case with the injection. They also stress the benefit of the vaccine far outweighs any risk associated with being immunized.
